Association of CYP MH spend per person aged 0–18 with explanatory factors (detailed physical care model)
| Detailed spend | SA 3 – QOF prevalence | |
| Ratio of means (SE) (95% CI) | Ratio of means (SE) (95% CI) | |
| Children entering youth justice per 1000 aged 0–18 | 1.03 (0.03) (0.97 to 1.09) | 1.04 (0.03) (0.99 to 1.10) |
| Children in need (family stress), rate per 100 aged 0–18 | 1.07 (0.05) (0.98 to 1.18) | 1.07 (0.05) (0.97 to 1.17) |
| Obese children (reception year) | 0.95 (0.06) (0.84 to 1.07) | 0.96 (0.06) (0.85 to 1.08) |
| Children with excess weight (reception year) | 1.04 (0.04) (0.97 to 1.12) | 1.04 (0.04) (0.98 to 1.12) |
| Children in care per 1000 aged 0–18 | 1.03 (0.02) (1.00 to 1.07) | 1.02 (0.02) (0.99 to 1.06) |
| Spend on MH per person over 18 (excl. CYP, £10) | 1.01 (0.01) (1.00 to 1.02) | 1.01 (0.01) (1.00 to 1.02) |
| Spend on circulatory disease per person: coronary heart disease | 1.01 (0.01) (0.98 to 1.03) | |
| Spend on circulatory disease per person: other | 0.98** (0.01) (0.97 to 0.99) | |
| Spend on respiratory disease per person: obstructive conditions | 1.01 (0.02) (0.98 to 1.04) | |
| Spend on cancer per person: bowel cancer | 1.02 (0.04) (0.95 to 1.10) | |
| Spend on maternity per person | 1.18 (0.10) (0.99 to 1.40) | |
| Percentage of black and minority ethnic | 0.99* (0.00) (0.98 to 1.00) | 0.99 (0.01) (0.98 to 1.01) |
| Overcrowding | 1.01 (0.01) (0.99 to 1.03) | 1.01 (0.01) (0.99 to 1.02) |
| Long-term unemployment | 1.02 (0.02) (0.99 to 1.05) | 1.03 (0.02) (1.00 to 1.06) |
| Cancer prevalence—18+, QOF | 0.93 (0.09) (0.77 to 1.13) | |
| Diabetes prevalence—18+, QOF | 0.94 (0.03) (0.86 to 1.03) | |
| COPD prevalence, QOF | 0.98 (0.09) (0.82 to 1.18) | |
| Observations | 199 | 199 |
| Akaike information criterion (AIC) | 1942 | 1939 |
| Bayesian information criterion (BIC) | 1991 | 1981 |
| Pseudo R-squared | 0.32 | 0.29 |
**P<0.05, **P<0.01, ***P<0.001.
COPD, chronic obstructive pulmonary disease; CYP MH, child and young person mental health; QOF, Quality and Outcome Frameworks; SA, sensitivity analysis.